We're eager to explore new methodologies and technologies in clinical trials and drug development, and to share our experiences on leveraging real-world imaging datasets (RWiD) as effective external control arms in trials, among other things. Our curated, fit-for-purpose regulatory grade datasets and multimodal longitudinal datasets can be leveraged as external control arms in clinical trials, delivering enhanced value and improving trial outcomes.